Anti-neoplastic Agents 2 - Antimetabolites Flashcards

1
Q

Antimetabolites: Purine Analog - 6-Mercaptopurine (6MP) MOA and Reduce dose when?

A

Activated by HGPRT to 6-thioinosinic monophosphate –> inhibition of purine nucleotide synthesis

Reduce dose if given with allopurinol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antimetabolites: Purine Analog - 6-thioguanine (6TG) (1)

A

No dose modification with allopurinol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antimetabolites: Pyrimidine Antagonists - 5-fluorouracil (5FU) (MOA (2)

A

5FU –> Fdump

Inhibits thymidylate synthase –> thymineless death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antimetabolites: Pyrimidine Antagonists - 5-fluorouracil (5FU) Toxicities (4)

A
  1. Nausea
  2. Mucositis (esophageal ulcers)
  3. Diarrhea
  4. Hand and foot syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antimetabolites: Pyrimidine Antagonists - 5-fluorouracil (5FU) Capecitabine MOA

A

Convereted to fluorouracil in the tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antimetabolites: Pyrimidine Antagonists - 5-fluorouracil (5FU) Cytarabine Dependent and Use

A

Highly schedule dependent (S phase)

Used in acute myelogenous leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antimetabolites: Folate Antagonist - Methotrexate (MTX) MOA (4)

A

Inhibits dihydrofolate reductase (DHFR)

Tetrahydrofolate not synthesized

Inhibits DNA, RNA, and protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antimetabolites: Folate Antagonist - Normal cells require folic acid, so what do we do?

A

Leucovorin rescue (folinic acid)

Antidote to methotrexate toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antimetabolites: Others - Hydroxyurea Use (2)

A

Used for CML

Used for Sickle Cell Anemia (low dose) –> increase fetal Hbf synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Antibiotics (Anthracyclines): Doxorubicin and Daunorubicin MOA (3)
A
  1. Inhibits topoisomerase II
  2. Binds to DNA through intercalation blockade of the synthesis of DNA and RNA, and DNA strand scission
  3. Generation of semiquinone free radicals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Antibiotics (Anthracyclines): Doxorubicin and Daunorubicin Side Effects (3) and Antidote
A
  1. Cardiotoxicity (side effects)
  2. Acute: pericarditis, arrythmia, ECG changes
  3. Chronic: CHF

Antidote: Dexrazoxane (prevents CHF) - chelating agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Antibiotics (Anthracyclines): Radiation Recall Reaction - Bleomycin MOA
A

Causes DNA strand scission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Antibiotics (Anthracyclines): Radiation Recall Reaction - Bleomycin Side effects (2)
A
  1. Pulmonary toxicity (pneumonitis with cough, dyspnea, rales, infiltrates)
  2. Skin (redness, hyperpigmentation, and skin tenderness)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Mitotic Inhibitors: Vinca Alkaloids MOA (2)
A

Bind to tubulin: block microtubular polymerization

Cell division is arrested in meta phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Mitotic Inhibitors: Vinca Alkaloids - Vinblastine Side Effects (2)
A
  1. Bone marrow suppression

2. Alopecia (side effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. Mitotic Inhibitors: Vinca Alkaloids - Vincristine Side Effects (1)
A

Peripheral neuropathy

17
Q
  1. Mitotic Inhibitors: Vinca Alkaloids - Vinorelbine Side Effect (1)
A

Bone Marrow Suppression

18
Q
  1. Mitotic Inhibitors: Taxanes - Paclitaxel (Taxol) MOA
A

Enhancement of tubulin polymerization

19
Q
  1. Mitotic Inhibitors: Taxanes - Paclitaxel (Taxol) Rx of (3)
A
  1. Breast cancer
  2. Lung cancer
  3. Ovarian cancer
20
Q
  1. Mitotic Inhibitors: Taxanes - Docetaxel Rx of (1)
A

Advanced breast cancer

21
Q
  1. Mitotic Inhibitors: Taxanes - Paclitazel and Docetaxel are metabolized by?
A

Cytochrome P450

22
Q
  1. Miscellaneous: Topoisomerase Inhibitors - 2 types and use
A
  1. Etopside and Teniposide: lung cancer

2. Irinotecan and Topotecan: colorectal cancer

23
Q
  1. Miscellaneous: Enzymes - L-Asparaginase MOA
A

Catalyses hydrolysis L-asparagine to aspartic acid (tumor cells require L-asparagine for growth)

24
Q
  1. Miscellaneous: - L-Asparaginase Side Effects (1)
A

Pancreatitis

25
Q
  1. Miscellaneous: Tyrosine Kinase Inhibitors - Imatinib (GLEEVEC) MOA (2) and Use (1)
A

Inhibitor of tyrosine kinase domain bcr-able oncoprotein

Prevents the phosphorylation of kinase substrate by ATP

First line therapy in chronic phase of CML and blast crisis

26
Q
  1. Miscellaneous: Tyrosine Kinase Inhibitors - Vemurafenib (2)
A
  1. B-raf enzyme inhibitor

2. Used in melanoma patients whose cancer has a V600E BRAF mutation

27
Q
  1. Miscellaneous: Growth Factor Receptor Inhibitors - Gefitinib (IRESSA) and Erlotinib (TARCEVA) MOA
A

Inhibitor of the tyrosine kinase domain assoicated with the EGFR (epidermal growth factor receptor)

Used in non-small cell lung cancer

28
Q
  1. Miscellaneous: Growth Factor Receptor Inhibitors - Cetuximab (ERBITUX)
A

EGFR inhibitor used in metastatic colorectal cancer

29
Q
  1. Miscellaneous: Growth Factor Receptor Inhibitors - Rituximab (RITUXAN) Target and Use (2)
A

Attacks CD20

Used in B cell lymphoma

30
Q
  1. Miscellaneous: Growth Factor Receptor Inhibitors - Trastuzamab (HERCEPTIN) Target and Use
A

HER2/Neu (ErbB-2)

Used in breast cancer

31
Q
  1. Miscellaneous: Growth Factor Receptor Inhibitors - Lapatinib (TYKERB) Chemo protocols
A

Hodgkin’s Disease: ABVD region

Adriamycin (doxorubicin)
Bleomycin
Vinblastine
Dacarbazine

32
Q

Resistance to Chemotherapy: Formation of cancer drug inactivating enzymes

A

6-mercaptopurine and 5-FU

33
Q

Resistance to Chemotherapy: Decrease of binding affinity and drug sensitivty (4)

A
  1. Etoposide
  2. Methotrexate
  3. Vincristine
  4. Vinblastine
34
Q

Resistance to Chemotherapy: Decrease drug accumulation or permeability (3)

A
  1. Methotrexate
  2. Dactinomycin
  3. Cyclophosphamide
35
Q

Resistance to Chemotherapy: Chemical Reactions Inactivating Chemotherapy (3)

A
  1. Cyclophosphamide
  2. Bleomycin
  3. Cisplatin
36
Q

Resistance to Chemotherapy: Increased nucleic acid repair mechanism (2)

A
  1. Cisplatin

2. Cyclophosphamide

37
Q

Resistance to Chemotherapy: Reduced activation of pro-drgs 2)

A
  1. 6-mercaptopurine

2. 5 FU

38
Q

Resistance to Chemotherapy: Multdrug resistances MOA (2)

A
  1. Increased expression of MDR1 gene for P-glycoprotein

2. Overexpression of the multidrug resistance protein 1 (MRP1_ t